2025-01-012025-12-312025-12-31false12401287PURE HEALTHCARE GROUP LIMITED2026-09-16falseiso4217:GBPxbrli:pure124012872024-12-31124012872025-12-31124012872025-01-012025-12-31124012872023-12-31124012872024-12-31124012872024-01-012024-12-3112401287bus:SmallEntities2025-01-012025-12-3112401287bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3112401287bus:AbridgedAccounts2025-01-012025-12-3112401287bus:PrivateLimitedCompanyLtd2025-01-012025-12-3112401287core:WithinOneYear2025-12-3112401287core:AfterOneYear2025-12-3112401287core:WithinOneYear2024-12-3112401287core:AfterOneYear2024-12-3112401287core:ShareCapital2025-12-3112401287core:SharePremium2025-12-3112401287core:RevaluationReserve2025-12-3112401287core:OtherReservesSubtotal2025-12-3112401287core:RetainedEarningsAccumulatedLosses2025-12-3112401287core:ShareCapital2024-12-3112401287core:SharePremium2024-12-3112401287core:RevaluationReserve2024-12-3112401287core:OtherReservesSubtotal2024-12-3112401287core:RetainedEarningsAccumulatedLosses2024-12-3112401287core:LandBuildings2025-12-3112401287core:PlantMachinery2025-12-3112401287core:Vehicles2025-12-3112401287core:FurnitureFittings2025-12-3112401287core:OfficeEquipment2025-12-3112401287core:NetGoodwill2025-12-3112401287core:IntangibleAssetsOtherThanGoodwill2025-12-3112401287core:ListedExchangeTraded2025-12-3112401287core:UnlistedNon-exchangeTraded2025-12-3112401287core:LandBuildings2024-12-3112401287core:PlantMachinery2024-12-3112401287core:Vehicles2024-12-3112401287core:FurnitureFittings2024-12-3112401287core:OfficeEquipment2024-12-3112401287core:NetGoodwill2024-12-3112401287core:IntangibleAssetsOtherThanGoodwill2024-12-3112401287core:ListedExchangeTraded2024-12-3112401287core:UnlistedNon-exchangeTraded2024-12-3112401287core:LandBuildings2025-01-012025-12-3112401287core:PlantMachinery2025-01-012025-12-3112401287core:Vehicles2025-01-012025-12-3112401287core:FurnitureFittings2025-01-012025-12-3112401287core:OfficeEquipment2025-01-012025-12-3112401287core:NetGoodwill2025-01-012025-12-3112401287core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112401287core:ListedExchangeTraded2025-01-012025-12-3112401287core:UnlistedNon-exchangeTraded2025-01-012025-12-3112401287core:MoreThanFiveYears2025-01-012025-12-3112401287core:Non-currentFinancialInstruments2025-12-3112401287core:Non-currentFinancialInstruments2024-12-3112401287dpl:CostSales2025-01-012025-12-3112401287dpl:DistributionCosts2025-01-012025-12-3112401287core:LandBuildings2025-01-012025-12-3112401287core:PlantMachinery2025-01-012025-12-3112401287core:Vehicles2025-01-012025-12-3112401287core:FurnitureFittings2025-01-012025-12-3112401287core:OfficeEquipment2025-01-012025-12-3112401287dpl:AdministrativeExpenses2025-01-012025-12-3112401287core:NetGoodwill2025-01-012025-12-3112401287core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112401287dpl:GroupUndertakings2025-01-012025-12-3112401287dpl:ParticipatingInterests2025-01-012025-12-3112401287dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3112401287core:ListedExchangeTraded2025-01-012025-12-3112401287dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3112401287core:UnlistedNon-exchangeTraded2025-01-012025-12-3112401287dpl:CostSales2024-01-012024-12-3112401287dpl:DistributionCosts2024-01-012024-12-3112401287core:LandBuildings2024-01-012024-12-3112401287core:PlantMachinery2024-01-012024-12-3112401287core:Vehicles2024-01-012024-12-3112401287core:FurnitureFittings2024-01-012024-12-3112401287core:OfficeEquipment2024-01-012024-12-3112401287dpl:AdministrativeExpenses2024-01-012024-12-3112401287core:NetGoodwill2024-01-012024-12-3112401287core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3112401287dpl:GroupUndertakings2024-01-012024-12-3112401287dpl:ParticipatingInterests2024-01-012024-12-3112401287dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3112401287core:ListedExchangeTraded2024-01-012024-12-3112401287dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3112401287core:UnlistedNon-exchangeTraded2024-01-012024-12-3112401287core:NetGoodwill2025-12-3112401287core:IntangibleAssetsOtherThanGoodwill2025-12-3112401287core:LandBuildings2025-12-3112401287core:PlantMachinery2025-12-3112401287core:Vehicles2025-12-3112401287core:FurnitureFittings2025-12-3112401287core:OfficeEquipment2025-12-3112401287core:AfterOneYear2025-12-3112401287core:WithinOneYear2025-12-3112401287core:ListedExchangeTraded2025-12-3112401287core:UnlistedNon-exchangeTraded2025-12-3112401287core:ShareCapital2025-12-3112401287core:SharePremium2025-12-3112401287core:RevaluationReserve2025-12-3112401287core:OtherReservesSubtotal2025-12-3112401287core:RetainedEarningsAccumulatedLosses2025-12-3112401287core:NetGoodwill2024-12-3112401287core:IntangibleAssetsOtherThanGoodwill2024-12-3112401287core:LandBuildings2024-12-3112401287core:PlantMachinery2024-12-3112401287core:Vehicles2024-12-3112401287core:FurnitureFittings2024-12-3112401287core:OfficeEquipment2024-12-3112401287core:AfterOneYear2024-12-3112401287core:WithinOneYear2024-12-3112401287core:ListedExchangeTraded2024-12-3112401287core:UnlistedNon-exchangeTraded2024-12-3112401287core:ShareCapital2024-12-3112401287core:SharePremium2024-12-3112401287core:RevaluationReserve2024-12-3112401287core:OtherReservesSubtotal2024-12-3112401287core:RetainedEarningsAccumulatedLosses2024-12-3112401287core:NetGoodwill2023-12-3112401287core:IntangibleAssetsOtherThanGoodwill2023-12-3112401287core:LandBuildings2023-12-3112401287core:PlantMachinery2023-12-3112401287core:Vehicles2023-12-3112401287core:FurnitureFittings2023-12-3112401287core:OfficeEquipment2023-12-3112401287core:AfterOneYear2023-12-3112401287core:WithinOneYear2023-12-3112401287core:ListedExchangeTraded2023-12-3112401287core:UnlistedNon-exchangeTraded2023-12-3112401287core:ShareCapital2023-12-3112401287core:SharePremium2023-12-3112401287core:RevaluationReserve2023-12-3112401287core:OtherReservesSubtotal2023-12-3112401287core:RetainedEarningsAccumulatedLosses2023-12-3112401287core:AfterOneYear2025-01-012025-12-3112401287core:WithinOneYear2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112401287core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3112401287core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3112401287core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3112401287core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3112401287core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3112401287bus:Director12025-01-012025-12-3112401287bus:Director22025-01-012025-12-3112401287bus:Director32025-01-012025-12-31

PURE HEALTHCARE GROUP LIMITED

Registered Number
12401287
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

PURE HEALTHCARE GROUP LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

Joe Carter
Ross Carter
Tony Constantinides

Registered Address

214 Grangewood House 43 Oakwood Hill
Loughton

Registered Number

12401287 (England and Wales)
PURE HEALTHCARE GROUP LIMITED
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3-2,962
-2,962
Current assets
Debtors41,542,0812,176,288
Cash at bank and on hand33,13413,837
1,575,2152,190,125
Creditors amounts falling due within one year5(1,303,579)(1,767,365)
Net current assets (liabilities)271,636422,760
Total assets less current liabilities271,636425,722
Creditors amounts falling due after one year6(9,166)(19,166)
Net assets262,470406,556
Capital and reserves
Called up share capital9999
Profit and loss account262,371406,457
Shareholders' funds262,470406,556
The financial statements were approved and authorised for issue by the Board of Directors on 16 September 2026, and are signed on its behalf by:
Tony Constantinides
Director
Registered Company No. 12401287
PURE HEALTHCARE GROUP LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. .
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows

Straight line (years)
Plant and machinery5
2.Average number of employees

20252024
Average number of employees during the year2329
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 January 2511,189
At 31 December 2511,189
Depreciation and impairment
At 01 January 258,227
Charge for year2,962
At 31 December 2511,189
Net book value
At 31 December 25-
At 31 December 242,962
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables1,233,0651,784,183
Other debtors309,016392,105
Total1,542,0812,176,288
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables149,093164,595
Bank borrowings and overdrafts871,8921,249,334
Taxation and social security191,331236,661
Other creditors91,263116,775
Total1,303,5791,767,365
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts9,16619,166
Total9,16619,166